In one study of 80 patients with early PD, Shults and colleagues (2002) found that in comparison to placebo, 1200 mg of CoQ10 was associated with a slower decline in UPDRS and a positive trend in decline UPDRS decline favoring CoQ10.
1
—
—
In one study of 80 patients with early PD, Shults and colleagues (2002) found that in comparison to placebo, 1200 mg of CoQ10 was associated with a slower decline in UPDRS and a positive trend in decline UPDRS decline favoring CoQ10.